Early Pulmonary rehabilitation in COPD Patients may prevent risk of readmission in hospital

Chronic obstructive pulmonary disease (COPD) is one of the most common chronic conditions worldwide. Among Medicare beneficiaries 65 years or older admitted to the hospital with a COPD exacerbation, approximately 20% are readmitted within 30 days, and 64% are readmitted within 1 year of discharge. Recent study findings added further value to the current guideline recommendations surrounding the role of pulmonary rehabilitation (PR) after an exacerbation.
The researchers reported that early pulmonary rehabilitation following hospitalization with COPD was associated with a reduced risk of readmission in the following year. The study findings were published in the American Journal of Respiratory and Critical Care Medicine on July 20, 2021.
Based on the previous study findings, the American Thoracic Society, the European Respiratory Society, and the American College of Chest Physicians recommended initiation of PR within 3 weeks of an exacerbation for the treatment of patients with COPD. However, little is known about the effectiveness of PR in preventing readmissions in routine clinical practice settings, and results from prior studies are conflicting. Therefore, Dr Mihaela S. Stefan and her team conducted a study to evaluate the association between initiation of PR within 90 days of discharge and rehospitalization(s).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.